Pre-publication history
Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection
-
* Corresponding author: José M Navarro-Jarabo jnavarro@hcs.es
BMC Gastroenterology 2007, 7:31 doi:10.1186/1471-230X-7-31
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 22 Dec 2006 | |
| Reviewer's Report | Giovanni Cammarota | 10 Feb 2007 | |
| Reviewer's Report | TJ Borody | 19 Feb 2007 | |
| Reviewer's Report | Colm O'Morain | 07 Mar 2007 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 28 Mar 2007 |
| Resubmission - Version 3 | Manuscript | 29 Mar 2007 | |
| Reviewer's Report | TJ Borody | 27 Apr 2007 | |
| Reviewer's Report | Colm O'Morain | 21 May 2007 | |
| Resubmission - Version 6 | Manuscript | Author's comment | 05 Jul 2007 |
| Editorial acceptance | 10 Jul 2007 | ||
| Published | 25 Jul 2007 |